We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Interim Analysis Finds Moderna's mRNA Vaccine Has Efficacy of 94.5%

News   Nov 16, 2020 | Original story from the National Institutes of Health

 
Interim Analysis Finds Moderna's mRNA Vaccine Has Efficacy of 94.5%
 
 
Advertisement
 

RELATED ARTICLES

Presence of a Specific Bacterium Linked to IBS

News

Researchers have detected a connection between Brachyspira, a genus of bacteria in the intestines, and IBS.

READ MORE

How the CRISPR Immune System Evolved

News

New research results shed new light on how CRISPR-Cas emerged early during the development of life on Earth, as well as how this immune system is constantly adapting to new challenges.

READ MORE

What Causes Influenza Infections To Become Deadly?

News

It is largely unknown why influenza infections lead to an increased risk of bacterial pneumonia. However, researchers have now described important findings leading to so-called superinfections, which claim many lives around the world every year.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE